Abstract

Breast, ovarian, endometrial, prostate and cervical cancers are considered as the major endocrine-dependent malignancies associated with human reproductive system. Current tools used for diagnosis and therapeutics of these malignancies mainly exploit the hormone-sensitivity associated with them. Nonetheless, they often fail to give appreciable outcomes in terms of prognosis and survival rates. miRNAs have emerged as one of the key players dictating the pathophysiology of endocrine-dependent malignancies and present themselves as apt candidates to be developed as potential biomarkers or therapeutic targets for the early prognosis as well as treatment of these diseases. In this review, we have high-lighted the regulatory networks controlled by the promising candidate miRNAs in the pathophysiology of the major endocrinedependent reproductive system-associated malignancies.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.